ReviewLung Cancer (Auckland, N.Z.)2021

Managing Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors Through Co-Targeting MEK/ERK Signaling.

Danlei Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.